Literature DB >> 24591104

A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid beta.

Roberta Ricciarelli1, Daniela Puzzo, Olga Bruno, Elisa Canepa, Elena Gardella, Daniela Rivera, Lucia Privitera, Cinzia Domenicotti, Barbara Marengo, Umberto Maria Marinari, Agostino Palmeri, Maria Adelaide Pronzato, Ottavio Arancio, Ernesto Fedele.   

Abstract

Cyclic adenosine monophosphate (cAMP) regulates long-term potentiation (LTP) and ameliorates memory in healthy and diseased brain. Increasing evidence shows that, under physiological conditions, low concentrations of amyloid β (Aβ) are necessary for LTP expression and memory formation. Here, we report that cAMP controls amyloid precursor protein (APP) translation and Aβ levels, and that the modulatory effects of cAMP on LTP occur through the stimulation of APP synthesis and Aβ production.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24591104     DOI: 10.1002/ana.24130

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

Review 2.  Synaptic therapy in Alzheimer's disease: a CREB-centric approach.

Authors:  Andrew F Teich; Russell E Nicholls; Daniela Puzzo; Jole Fiorito; Rosa Purgatorio; Mauro Fa'; Ottavio Arancio
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

3.  A New Bistable Switch Model of Alzheimer's Disease Pathogenesis.

Authors:  Bruno Burlando; Serena Losacco; Viviana Villa; Ernesto Fedele; Roberta Ricciarelli
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

4.  Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease.

Authors:  Zhao Dai; Tian Hu; Shijie Su; Jinman Liu; Yinzhong Ma; Yue Zhuo; Shuhuan Fang; Qi Wang; Zhizhun Mo; Huafeng Pan; Jiansong Fang
Journal:  Front Pharmacol       Date:  2022-05-25       Impact factor: 5.988

5.  The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status.

Authors:  Walter Gulisano; Marcello Melone; Domenica D Li Puma; Maria Rosaria Tropea; Agostino Palmeri; Ottavio Arancio; Claudio Grassi; Fiorenzo Conti; Daniela Puzzo
Journal:  Neurobiol Aging       Date:  2018-07-18       Impact factor: 4.673

6.  A key role for TGF-β1 in hippocampal synaptic plasticity and memory.

Authors:  Filippo Caraci; Walter Gulisano; Chiara A Guida; Agata A R Impellizzeri; Filippo Drago; Daniela Puzzo; Agostino Palmeri
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

Review 7.  Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

Authors:  Sergio T Ferreira; Mychael V Lourenco; Mauricio M Oliveira; Fernanda G De Felice
Journal:  Front Cell Neurosci       Date:  2015-05-26       Impact factor: 5.505

Review 8.  The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.

Authors:  Roberta Ricciarelli; Ernesto Fedele
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.

Authors:  Shereen Nizari; Li Guo; Benjamin M Davis; Eduardo M Normando; Joana Galvao; Lisa A Turner; Mukhtar Bizrah; Mohammad Dehabadi; Kailin Tian; M Francesca Cordeiro
Journal:  Cell Death Dis       Date:  2016-12-08       Impact factor: 8.469

Review 10.  Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.

Authors:  Amy J Tibbo; Gonzalo S Tejeda; George S Baillie
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.